This doesn't mean that Big Pharma is not spending on innovation. They do. They spend on the marketing part. They spend on the D part of R & amp; D. They spend an awful lot on buying back their stock, which is quite problematic.
Eso no significa que Big Pharma no gaste en innovación. Lo hace. Gasta en mercadotecnia. Gasta en la D de la I + D. Gasta mucho en la recompra de sus acciones, algo problemático.